@Noreen,
LOL. The current patent system has given those big pharms too much advantage and it really hurts the entire society. I believe people will feel cheerful those big pharms losing more.
Decision Resources estimates that with the industry entering a period of significant patent expiries, and with ongoing economic headwinds and cost-containment efforts by payers worldwide, future growth looks anemic at best.
Over the next seven years, the global market is expected to record a compound annual growth rate of just 2.1 percent, reaching $817 billion in 2018.
At the company level, Pfizer retained its spot as the top pharmaceutical company by sales by a considerable margin last year, with $58 billion in ethical drug sales in 2011. However, with Lipitor now experiencing generic competition, Decision Resources expects Novartis to be the leading company by 2015, and for it to maintain this position throughout the remainder of the forecast period to 2018.
LOL...I got that impression, too. Not good to sound happy about disease!
Re: More disease, more money
Dex
4/18/2012 5:19:37 PM
That's one way of looking at it. But he doesn't have to sound so happy about new diseases and "old ones making a comeback"!
Merck KGaA chairman Dr. Karl-Ludwig Kley told Israel's Globes that there are plenty of new opportunities, patent cliff be damned.
"There are dramatic changes in the world. The patent cliff isn't one of them. The patent cliff is a snapshot of a company's situation. So long as there are patents, there will always be a patent cliff, but there are still a lot of new diseases, as well as old diseases that are making a comeback. There's a great need for innovation and humanity has a capacity to innovate. I am a strong believer in it."
Nice stats Noreen.
Yes I am always amazed when the Repubs talk about Dem healthcare plans they descrie "Keynesian Communism" but when you bring up Medicare Part D you just hear crickets. I don't get it. This is a socialized drug plan, pure and simple.
Here's some historical Part D expenditures:
| |
----total in billions
|
| 2004 |
$0.40 |
| 2005 |
1.1 |
| 2006 |
47.4 |
| 2007 |
49.7 |
| 2008 |
49.3 |
| 2009 |
60.8 |
| 2010 |
62 |
| 2011 |
67.1 |
| 2012 |
76.3 |
| 2013 |
85.2 |
| 2014 |
91.1 |
| 2015 |
100.2 |
| 2016 |
109.9 |
| 2017 |
120 |
| 2018 |
130.6 |
| 2019 |
141.9 |
| 2020 |
156.6 |
| |
$1,349.60 |
Part D outlays are estimated to increase from 0.4 percent of GDP in 2010 to about 1.7 percent by 2085, according to the US Centers for Medicare & Medicaid Services.
What about Medicare Part D? It was a Bush II plan. Its cost is estimated to be $800B. It's a giveaway to the pharma industry. But you don't really hear the Repubs talk about this much.
Re: Health Care Bill
ProfR
4/18/2012 7:47:43 AM
You are right, I think the health care bill has a negative effect if dealt with this way.
However, the I think the government is also forcing insurers to cover more drugs and more people. So this would increase volume demand.
I think these pharma companies will play the game and move the higher pricing to pills that the government and insurers says they will cover.
The blogs and comments posted on Investor Uprising do not reflect the views of Investor Uprising, PRNewswire, or its sponsors. Investor Uprising, PRNewswire, and its sponsors do not assume responsibility for any comments, claims, or opinions made by authors and bloggers. They are no substitute for your own research and should not be relied upon for trading or any other purpose.
|
 |
Latest Blogs
Telecom-equipment maker Ciena is a stock trader’s dream, as long as the timing is correct.
The FTC is offering a $50,000 cash prize to the person or group that can come up with a solution to those annoying robocalls.
Akamai is in the middle of four significant tech trends.
John Malone of Liberty Media will be taking over Sirius XM satellite radio when the existing CEO Mel Karmazin steps down. What's it mean?
Demand for students of the humanities exists, despite widespread aspersions on the discipline.
IU Education
Resources to help you become a better investor
Investor Uprising on Twitter
25 market-moving companies we're tracking
|
Tweet This